EFFECTS OF METFORMIN ADMINISTRATION ON ENDOCRINE-METABOLIC PARAMETERS, VISCERAL ADIPOSITY AND CARDIOVASCULAR RISK FACTORS IN CHILDREN WITH OBESITY AND RISK MARKERS FOR METABOLIC SYNDROME. A PILOT STUDY.